Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹779Cr
Rev Gr TTM
Revenue Growth TTM
-25.77%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

PQIF
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 76.9 | -9.3 | -33.7 | -27.6 | 18.0 | 71.5 | 77.3 | 24.1 | -46.2 | -33.2 | -11.1 | -3.0 |
| 21 | 14 | 12 | 13 | 26 | 25 | 22 | 16 | 13 | 16 | 20 | 15 |
Operating Profit Operating ProfitCr |
| 4.6 | 7.1 | 5.0 | 8.0 | 2.5 | 4.2 | 4.4 | 7.2 | 7.6 | 7.0 | 5.6 | 7.6 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -52.2 | -2.1 | -82.3 | 28.1 | 536.4 | 40.4 | 272.2 | -17.1 | -55.0 | 9.1 | 9.0 | 14.7 |
| 1.0 | 3.1 | 1.4 | 5.9 | 5.3 | 2.6 | 2.9 | 4.0 | 4.4 | 4.2 | 3.5 | 4.7 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 17.1 | -28.0 | -66.5 | 85.2 | 76.0 | 37.8 | -12.1 | 17.1 | -14.2 |
| 58 | 69 | 50 | 17 | 30 | 52 | 72 | 65 | 76 | 64 |
Operating Profit Operating ProfitCr |
| 5.4 | 4.1 | 3.7 | 0.8 | 5.1 | 7.2 | 7.0 | 5.1 | 5.5 | 6.9 |
Other Income Other IncomeCr | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 1 |
Interest Expense Interest ExpenseCr | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 2 | 1 | 0 | 0 | 2 | 4 | 4 | 4 | 4 |
| 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
|
| | -10.4 | -42.1 | -157.3 | 199.1 | 327.2 | 64.7 | 22.0 | -8.2 | 8.4 |
| 1.9 | 1.4 | 1.1 | -1.9 | 1.0 | 2.5 | 3.0 | 4.2 | 3.3 | 4.2 |
| 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| 113 | 114 | 115 | 114 | 115 | 117 | 119 | 121 | 124 | 125 |
Current Liabilities Current LiabilitiesCr | 16 | 15 | 13 | 12 | 13 | 23 | 26 | 16 | 21 | 27 |
Non Current Liabilities Non Current LiabilitiesCr | 8 | 8 | 9 | 11 | 10 | 9 | 7 | 8 | 6 | 7 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 20 | 17 | 11 | 10 | 10 | 20 | 22 | 13 | 19 | 25 |
Non Current Assets Non Current AssetsCr | 184 | 187 | 194 | 194 | 195 | 196 | 197 | 199 | 199 | 201 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 4 | 2 | 5 | 1 | 2 | 3 | 6 | 4 | 3 |
Investing Cash Flow Investing Cash FlowCr | -5 | -1 | -7 | -1 | 0 | 0 | -1 | -3 | 0 |
Financing Cash Flow Financing Cash FlowCr | 2 | -1 | 0 | 0 | -2 | -3 | -4 | -1 | -3 |
|
Free Cash Flow Free Cash FlowCr | 4 | 2 | 5 | 1 | 2 | 3 | 6 | 2 | 2 |
| 334.0 | 244.5 | 931.5 | -177.0 | 705.1 | 209.7 | 236.8 | 153.0 | 94.9 |
CFO To EBITDA CFO To EBITDA% | 113.7 | 85.1 | 288.2 | 453.8 | 143.9 | 73.3 | 102.2 | 125.0 | 56.4 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 745 | 607 | 94 | 34 | 2,323 | 1,371 | 1,370 | 1,848 |
Price To Earnings Price To Earnings | 0.0 | 740.0 | 1,004.4 | 0.0 | 100.0 | 1,730.0 | 583.3 | 453.4 | 688.1 |
Price To Sales Price To Sales | 0.0 | 10.3 | 11.6 | 5.3 | 1.0 | 41.0 | 17.7 | 19.8 | 22.7 |
Price To Book Price To Book | 0.0 | 4.7 | 3.8 | 0.6 | 0.2 | 14.4 | 8.4 | 8.3 | 11.0 |
| 2.4 | 258.3 | 326.5 | 826.7 | 29.7 | 571.8 | 253.7 | 393.4 | 418.3 |
Profitability Ratios Profitability Ratios |
| 14.1 | 10.7 | 12.7 | 22.9 | 15.7 | 15.1 | 17.4 | 20.4 | 21.9 |
| 5.4 | 4.1 | 3.7 | 0.8 | 5.1 | 7.2 | 7.0 | 5.1 | 5.5 |
| 1.9 | 1.4 | 1.1 | -1.9 | 1.0 | 2.5 | 3.0 | 4.2 | 3.3 |
| 1.8 | 1.6 | 1.1 | 0.3 | 0.9 | 1.9 | 2.7 | 2.7 | 2.6 |
| 0.6 | 0.6 | 0.3 | -0.2 | 0.2 | 0.8 | 1.3 | 1.5 | 1.4 |
| 0.6 | 0.5 | 0.3 | -0.2 | 0.2 | 0.7 | 1.1 | 1.4 | 1.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
**Polo Queen Industrial and Fintech Limited (PQIFL)**, established in **1984**, is a diversified multi-divisional enterprise under the **House of Rajkamal**. Headquartered in Mumbai, the company has evolved from a trading entity into a multi-sector conglomerate with interests spanning Fast-Moving Consumer Goods (FMCG), specialty chemicals, minerals, financial services, and information technology. The company is currently undergoing a strategic transition toward high-value manufacturing and digital infrastructure through large-scale greenfield projects.
---
### **Core Business Verticals and Market Presence**
The company’s operations are organized into specialized divisions and wholly-owned subsidiaries, each targeting distinct market segments:
* **FMCG (Doan Rajkamal):** This is the company’s flagship division, marketing a wide array of personal, home, kitchen, and fabric care products under the **POLOQUEEN** brand.
* **Market Reach:** Serves the Indian civilian market and is a registered supplier to the **Indian Defence Forces**.
* **Brand Strategy:** In **May 2024**, the company signed Bollywood celebrity **Raveena Tandon** as Brand Ambassador to drive pan-India acceptance and visibility.
* **Distribution:** Utilizes a "smart pricing" model to target the "common man" through modern trade, e-commerce, and a robust network of traditional dealers and retailers.
* **Chemicals & Minerals (Polo Queen Minchems):** Engaged in trading specialty chemicals and minerals for the foundry and steel industries. The company is revitalizing this segment by sourcing raw materials from **African mines** and hiring technical experts.
* **Financial Services (Polo Queen Capital Ltd):** A wholly-owned **NBFC** registered with the **RBI** (since Sept 2017). It manages equity investments through portfolio management consultants.
* **Information Technology:** Focused on the development of **I.T. Parks** and digital infrastructure.
* **Pharma Trade:** Managed via **Polo Queen Pharma Trade Industry Limited**, with active business plans currently under development.
---
### **Product Portfolio: The POLOQUEEN Brand**
The company’s FMCG portfolio is designed for high-volume consumption across diverse demographics:
| Segment | Key Product Categories |
| :--- | :--- |
| **Kitchen Care** | **Kitchen Essentials**, **Slickuropp** (Cling Film), **Slick** (Paper Napkins), **Shudh** (Organic products) |
| **Personal Care** | High-quality hygiene and grooming products for all age groups |
| **Fabric Care** | Specialized laundry detergents and textile maintenance solutions |
| **Home Care** | General household utility and cleaning agents |
---
### **Strategic Growth: Greenfield "Mega Projects"**
PQIFL is pivoting toward capital-intensive manufacturing and infrastructure through two major initiatives in Maharashtra:
1. **Mahad Agro-Processing Project:**
* Conferred **'Mega Project'** status by the Government of Maharashtra under the **PSI 2019** scheme.
* Focus: Processing cash crops to produce **Bioethanol** and pharmaceutical-grade import substitutes.
* Target Markets: Food, Pharmaceuticals, Electronics, and Poultry Feed (Domestic & Export).
2. **Dombivli Data Centre:**
* A proposed digital infrastructure project located near Navi Mumbai.
* Strategy: To capitalize on the surge in domestic data consumption and the national digital transformation.
---
### **Financial Performance and Capital Structure**
The company has demonstrated consistent topline growth and improved profitability margins over the recent fiscal periods.
**Consolidated Financial Summary:**
| Metric | FY 2022-23 | FY 2023-24 | FY 2024-25 |
| :--- | :---: | :---: | :---: |
| **Total Revenue** | ₹77.90 Cr | ₹70.64 Cr | **₹81.58 Cr** |
| **Revenue Growth (YoY)** | 37.7% | -9.3% | **15.5%** |
| **Net Profit (PAT)** | ₹2.29 Cr | ₹1.26 Cr* | **₹1.85 - 2.60 Cr** |
| **PAT Margin** | 2.94% | 1.84%* | **~4.0% - 4.2%** |
*\*Standalone figures for FY24; consolidated PAT for FY25 reflects growth across subsidiaries.*
**Capital and Debt Profile:**
* **Paid-Up Capital:** **₹67.15 Crore** (33.575 crore shares at ₹2 each).
* **Debt Reduction:** Secured bank borrowings decreased from **₹7.07 Crore** to **₹4.74 Crore** as of March 31, 2025.
* **Credit Ratings (CRISIL):** Reaffirmed in Sept 2025 as **CRISIL BB-/Stable** (Long Term) and **CRISIL A4+** (Short Term).
* **Funding Pipeline:** The Board has approved a fundraising ceiling of **₹2,500 Crore** to finance Mega Projects. Additionally, a **₹100 Crore** loan from **Sanghai Holdings Private Limited** was proposed in April 2025 for working capital and debt repayment.
---
### **Subsidiary Operations (FY 2024-25)**
The company’s three wholly-owned subsidiaries contribute to the consolidated bottom line, with the NBFC arm being the primary contributor:
| Subsidiary | Purpose | Networth / Assets | Annual Profit |
| :--- | :--- | :--- | :--- |
| **Polo Queen Capital Ltd** | NBFC / Investments | **₹7.57 Crore (Assets)** | **₹97.12 Lakhs** |
| **Polo Queen Solutions Ltd** | General Corporate | **₹5.04 Lakhs (Assets)** | **₹0.07 Lakhs** |
| **Polo Queen Pharma Trade** | Pharma Trading | **₹5.04 Lakhs (Assets)** | **₹0.06 Lakhs** |
---
### **Operational Infrastructure and Security**
* **Asset Backing:** Bank facilities are secured by a **1st Charge** on property at **MIDC Mahad** and a **Negative Lien** on property at **MIDC Dombivli**.
* **Working Capital:** Secured via hypothecation of stock and debtors; overdrafts are specifically secured against **Government supply bills** (Defence sector).
* **Human Capital:** The company employs **33** permanent staff. In FY25, the average employee salary increased by **66.49%**, reflecting a competitive talent retention strategy.
* **Sustainability:** As the company currently operates primarily as a trading entity, Extended Producer Responsibility (EPR) is currently marked as **Not Applicable**, though the company is moving toward **green, biodegradable specialty additives** in its chemical division.
---
### **Risk Matrix and Regulatory Oversight**
PQIFL operates under a structured risk management framework but faces notable regulatory and market challenges:
**1. Regulatory Scrutiny:**
* **SEBI Investigation:** In **March 2025**, SEBI conducted search operations at the premises of the company’s **Promoters** regarding alleged **stock price manipulation** via social media.
* **Disclosure Lapses:** SEBI issued an administrative warning in **May 2025** for inadequate responses to unverified social media claims regarding a rumored **₹3,000 Crore** order and inflated revenue figures.
* **Compliance Penalties:** The **MSEI** imposed a penalty for a delay in filing investor grievance reports in early 2025.
**2. Financial and Market Risks:**
* **Financial Closure:** The execution of the **₹2,500 Crore** Mega Projects is contingent upon successful fundraising negotiations which are currently ongoing.
* **Input Volatility:** Exposure to fluctuations in **commodity prices**, packaging, and freight costs.
* **Credit & Liquidity:** Managed through strict credit limits for customers and rolling cash flow forecasts to ensure debt obligations are met.
**3. Internal Controls:**
* The company maintains a **Risk Management Committee** and an **Audit Committee**. Statutory auditors have issued an **unmodified opinion** on the effectiveness of internal financial controls for the most recent fiscal year.